Ironwood Pharma (IRWD) Reports Q1 Lost Per Share of 24c

Ironwood Pharma (NASDAQ: IRWD) reported Q1 EPS of ($0.24), may note compare the analyst estimate of ($0.23). Revenue for the quarter came in at $28.9 million versus the consensus estimate of $32.3 million.

For earnings history and earnings-related data on Ironwood Pharma (IRWD) click here.

You May Also Be Interested In

• Plexus Corp (PLXS) Tops Q2 EPS by 7c
• Celestica (CLS) Tops Q1 EPS by 14c
• VIST Financial Corp. (VIST) Misses Q1 EPS by 19c